Literature DB >> 20221642

An oral history of MASCC, its origin and development from MASCC's beginnings to 2009.

Cynthia N Rittenberg1, Judith L Johnson, Gerald M Kuncio.   

Abstract

INTRODUCTION: This paper presents an oral history from the mid-1980s to 2009 of the start and evolution of the Multinational Association of Supportive Care in Cancer (MASCC) as seen through the recollections of the founders and early leaders. The growth of the supportive cancer care movement and MASCC's contribution to oncology supportive care is described. DISCUSSION: As science was making progress towards better cancer treatment, a group of professionals began to research ways to prevent or mitigate the symptoms and side effects that accompany the disease and its treatments. Joining forces, they created an international, multidisciplinary organization to address and promulgate evidence-based practices of cancer supportive care. Through annual international scientific symposia, a peer-reviewed journal, an accessible website, and study group projects such as guidelines and tools, MASCC is accomplishing its mission.

Entities:  

Mesh:

Year:  2010        PMID: 20221642     DOI: 10.1007/s00520-010-0830-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  20 in total

Review 1.  Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.

Authors:  Lawrence H Einhorn; Bernardo Rapoport; Jim Koeller; Steven M Grunberg; Petra Feyer; Cynthia Rittenberg; Matti Aapro
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

Review 2.  Emesis induced by low or minimal emetic risk chemotherapy.

Authors:  Maurizio Tonato; Rebecca A Clark-Snow; David Osoba; Albano Del Favero; Enzo Ballatori; Sussanne Borjeson
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

3.  Unmasking MASCC. Multinational Association of Supportive Care in Cancer.

Authors: 
Journal:  Support Care Cancer       Date:  1993-01       Impact factor: 3.603

Review 4.  Anticipatory nausea and vomiting.

Authors:  Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2004-12-15       Impact factor: 3.603

Review 5.  Acute emesis: moderately emetogenic chemotherapy.

Authors:  Jørn Herrstedt; Jim M Koeller; Fausto Roila; Paul J Hesketh; David Warr; Cynthia Rittenberg; Mario Dicato
Journal:  Support Care Cancer       Date:  2004-11-23       Impact factor: 3.603

6.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

7.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

8.  Development of the MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer.

Authors:  Sultan Kav; Lisa Schulmeister; Anita Nirenberg; Linda Barber; Judi Johnson; Cynthia Rittenberg
Journal:  Support Care Cancer       Date:  2009-07-10       Impact factor: 3.603

9.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

10.  Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.

Authors:  Alexander Molassiotis; Peter A Coventry; Carrie T Stricker; Caroline Clements; Beth Eaby; Luke Velders; Cynthia Rittenberg; Richard J Gralla
Journal:  J Pain Symptom Manage       Date:  2007-05-23       Impact factor: 3.612

View more
  4 in total

Review 1.  Prevention of pelvic radiation disease.

Authors:  Lorenzo Fuccio; Leonardo Frazzoni; Alessandra Guido
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-02-06

2.  The financial hazard of personalized medicine and supportive care.

Authors:  Pricivel M Carrera; Ian Olver
Journal:  Support Care Cancer       Date:  2015-08-27       Impact factor: 3.603

3.  Patients' and parents' views regarding supportive care in childhood cancer.

Authors:  L J A Tenniglo; E A H Loeffen; L C M Kremer; A Font-Gonzalez; R L Mulder; A Postma; M C Naafs-Wilstra; M A Grootenhuis; M D van de Wetering; W J E Tissing
Journal:  Support Care Cancer       Date:  2017-04-29       Impact factor: 3.603

4.  Now we are 30: 10 more years of MASCC.

Authors:  Ian N Olver; Melissa Chin; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2021-01-23       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.